# Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States

> **NCT02569307** · PHASE2 · COMPLETED · sponsor: **Pakistan Institute of Living and Learning** · enrollment: 326 (actual)

## Conditions studied

- At Risk Mental State (ARMS)
- Psychosis

## Interventions

- **DRUG:** Minocycline
- **DRUG:** Omega-3 fatty acids
- **DRUG:** Placebo
- **DRUG:** Minocycline Plus Omega-3 fatty acids

## Key facts

- **NCT ID:** NCT02569307
- **Lead sponsor:** Pakistan Institute of Living and Learning
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2018-12
- **Final completion:** 2019-03
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2019-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02569307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02569307, "Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02569307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*